News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication May 14, 2019 Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn’s Disease Brian Feagan, Guangyong Zou, Vipul Jairath Read Now
Publication May 14, 2019 Responsiveness of Histological Disease Activity Indices in Ulcerative Colitis: A Post Hoc Analysis Using Data From the TOUCHSTONE Randomised Controlled Trial Brian Feagan, Guangyong Zou, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Pouchitis for the Development of a Core Outcome Set Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Innovations in Oral Therapies for Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 What Is the Role of C-Reactive Protein and Fecal Calprotectin in Evaluating Crohn’s Disease Activity? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
